Legal & General Group
NEO icon

Legal & General Group’s NeoGenomics NEO Stock Holding History

Legal & General Group’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.19M Sell
295,152
-29,037
-9% -$306K ﹤0.01% 1876
2025
Q4 		$3.81M Sell
324,189
-16,409
-5% -$177K ﹤0.01% 1709
2025
Q3 		$2.63M Sell
340,598
-11,718
-3% -$82.1K ﹤0.01% 1870
2025
Q2 		$2.58M Buy
352,316
+3,923
+1% +$31.7K ﹤0.01% 1863
2025
Q1 		$3.31M Sell
348,393
-8,421
-2% -$105K ﹤0.01% 1720
2024
Q4 		$5.88M Buy
356,814
+2,660
+0.8% +$41.3K ﹤0.01% 1498
2024
Q3 		$5.22M Sell
354,154
-2,242
-0.6% -$35.1K ﹤0.01% 1555
2024
Q2 		$4.94M Sell
356,396
-290
-0.1% -$4.11K ﹤0.01% 1531
2024
Q1 		$5.61M Buy
356,686
+74
+0% +$1.14K ﹤0.01% 1454
2023
Q4 		$5.77M Buy
356,612
+1,232
+0.3% +$20.2K ﹤0.01% 1435
2023
Q3 		$4.37M Sell
355,380
-7,016
-2% -$104K ﹤0.01% 1515
2023
Q2 		$5.82M Sell
362,396
-4,835
-1% -$79.7K ﹤0.01% 1373
2023
Q1 		$6.39M Buy
367,231
+3,641
+1% +$51.9K ﹤0.01% 1300
2022
Q4 		$3.36M Buy
363,590
+9,110
+3% +$84.9K ﹤0.01% 1620
2022
Q3 		$3.05M Sell
354,480
-1,063
-0.3% -$10.6K ﹤0.01% 1636
2022
Q2 		$2.9M Sell
355,543
-90,325
-20% -$862K ﹤0.01% 1692
2022
Q1 		$5.42M Buy
445,868
+15,486
+4% +$326K ﹤0.01% 1479
2021
Q4 		$14.7M Buy
430,382
+37,282
+9% +$1.46M ﹤0.01% 1013
2021
Q3 		$19M Buy
393,100
+27,381
+7% +$1.27M 0.01% 898
2021
Q2 		$16.5M Sell
365,719
-74,269
-17% -$3.29M 0.01% 951
2021
Q1 		$21.2M Buy
439,988
+66,839
+18% +$3.48M 0.01% 864
2020
Q4 		$20.1M Buy
373,149
+13,763
+4% +$622K 0.01% 844
2020
Q3 		$13.3M Buy
359,386
+4,715
+1% +$175K 0.01% 913
2020
Q2 		$11M Buy
354,671
+33,884
+11% +$939K 0.01% 949
2020
Q1 		$8.87M Buy
320,787
+27,730
+9% +$831K 0.01% 949
2019
Q4 		$8.57M Buy
293,057
+20,203
+7% +$481K ﹤0.01% 1083
2019
Q3 		$5.22M Buy
272,854
+32,622
+14% +$765K ﹤0.01% 1286
2019
Q2 		$5.27M Buy
240,232
+18,129
+8% +$398K ﹤0.01% 1254
2019
Q1 		$4.54M Buy
222,103
+210,139
+1,756% +$3.65M ﹤0.01% 1242
2018
Q4 		$151K Buy
11,964
+1,405
+13% +$20.9K ﹤0.01% 2367
2018
Q3 		$162K Buy
10,559
+963
+10% +$13.3K ﹤0.01% 2381
2018
Q2 		$125K Sell
9,596
-456
-5% -$5.02K ﹤0.01% 2427
2018
Q1 		$82K Sell
10,052
-3,658
-27% -$29.6K ﹤0.01% 2536
2017
Q4 		$122K Sell
13,710
-1,666
-11% -$15.4K ﹤0.01% 2492
2017
Q3 		$171K Buy
15,376
+2,152
+16% +$20.9K ﹤0.01% 2398
2017
Q2 		$120K Hold
13,224
– – ﹤0.01% 2506
2017
Q1 		$103K Sell
13,224
-292
-2% -$2.38K ﹤0.01% 2520
2016
Q4 		$116K Buy
13,516
+6,156
+84% +$52.7K ﹤0.01% 2471
2016
Q3 		$58K Hold
7,360
– – ﹤0.01% 2445
2016
Q2 		$58K Buy
7,360
+1,815
+33% +$14.5K ﹤0.01% 2395
2016
Q1 		$37K Buy
+5,545
New +$36.5K ﹤0.01% 2532

Other funds holding NEO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $2.23B AUM 12.38% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

Legal & General Group's NEO Position: Q1 2026 in Review

Legal & General Group reduced its NeoGenomics (NEO) stake by 9% in Q1 2026, selling an estimated $306K and leaving 295,152 shares worth $2.19M. The position accounts for ﹤0.01% of the portfolio, ranked #1876.

Legal & General Group first reported a position in NEO in Q1 2016 and has held it in 41 quarters since. The position peaked at $21.2M in Q1 2021. 253 funds tracked by Wall St. Rank hold NEO as of Q1 2026.

  • Legal & General Group held 295,152 shares of NeoGenomics worth $2.19M as of Q1 2026.
  • Legal & General Group sold 29,037 NeoGenomics shares in Q1 2026, an estimated $306K.
  • NeoGenomics made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #1876 holding.
  • Legal & General Group first reported a position in NeoGenomics in Q1 2016 and has held it in 41 quarters since.
  • Legal & General Group's NeoGenomics position peaked at $21.2M in Q1 2021.
  • 253 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.